GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PsyBio Therapeutics Corp (OTCPK:PSYBF) » Definitions » Net Margin %

PsyBio Therapeutics (PsyBio Therapeutics) Net Margin % : 0.00% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PsyBio Therapeutics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. PsyBio Therapeutics's Net Income for the three months ended in Jun. 2023 was $-0.18 Mil. PsyBio Therapeutics's Revenue for the three months ended in Jun. 2023 was $0.00 Mil. Therefore, PsyBio Therapeutics's net margin for the quarter that ended in Jun. 2023 was 0.00%.

The historical rank and industry rank for PsyBio Therapeutics's Net Margin % or its related term are showing as below:


PSYBF's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -157.59
* Ranked among companies with meaningful Net Margin % only.

PsyBio Therapeutics Net Margin % Historical Data

The historical data trend for PsyBio Therapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PsyBio Therapeutics Net Margin % Chart

PsyBio Therapeutics Annual Data
Trend Dec21 Dec22
Net Margin %
- -

PsyBio Therapeutics Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PsyBio Therapeutics's Net Margin %

For the Biotechnology subindustry, PsyBio Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PsyBio Therapeutics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PsyBio Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where PsyBio Therapeutics's Net Margin % falls into.



PsyBio Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

PsyBio Therapeutics's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-4.886/0
= %

PsyBio Therapeutics's Net Margin for the quarter that ended in Jun. 2023 is calculated as

Net Margin=Net Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-0.182/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PsyBio Therapeutics  (OTCPK:PSYBF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


PsyBio Therapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of PsyBio Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PsyBio Therapeutics (PsyBio Therapeutics) Business Description

Traded in Other Exchanges
Address
4400 Sample Road, Suite 138, Coconut Creek, FL, USA, 33073
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.

PsyBio Therapeutics (PsyBio Therapeutics) Headlines